CYP2E1 polymorphism, acetylator profiles and drug-induced liver injury incidence of Indonesian tuberculosis patients

Perwitasari, Dyah Aryani and Irham, Lalu Muhammad and Darmawan, Endang and Mulyani, Ully Adhie and Atthobari, Jarir (2016) CYP2E1 polymorphism, acetylator profiles and drug-induced liver injury incidence of Indonesian tuberculosis patients. [Artikel Dosen]

Text 1332Indian Journal of Tuberculosis.pdf Download (257kB)

Abstract

Objective: A polymorphism of CYP2E1 may be directly associated with the development of INH hepatotoxicity. We conducted this study to evaluate the association between polymorphisms of CYP2E1, Isoniazid (INH) concentration and the acetylator status of INH in cases of Indonesian tuberculosis patients with drug-induced liver disease (DILI).
Methods: We conducted our study with a cohort design consisting of 55 Indonesian adult tuberculosis (TB) patients. Acetylating phenotypes were studied in using the metabolic ratio of plasma AcHZ/HZ. DILI was defined using CTCAV version 4.0. The allelic and genotypic
frequency distributions of CYP2E1 rs 3813867 were studied using the polymerase chain reaction – amplification refractory mutation system (ARMS) methodology.
Results: Patients with an INH concentration of more than 7 mg/mL showed a higher risk of developing DILI when compared with patients who showed a therapeutic range of 3–6 mg/mL INH (OR: 1.3, 95% CI: 0.2–8.2). Slow acetylators had a higher incidence of DILI when compared
with rapid acetylators (OR: 4.6, 95% CI: 1.3–15.9). Meanwhile, subjects with GC had a higher risk of DILI incidence (OR: 4.3, 95% CI: 0.8–24.4).
Conclusion: Our study shows that polymorphisms of CYP2E1 and slow acetylator may have
role in the DILI incidence.

Item Type:	Artikel Dosen
Subjects:	R Medicine > RM Therapeutics. Pharmacology R Medicine > RS Pharmacy and materia medica
Depositing User:	dyah aryani
Date Deposited:	05 Sep 2019 05:26
Last Modified:	05 Sep 2019 05:26
URI:	http://eprints.uad.ac.id/id/eprint/14481

Actions (login required)

View Item